Edible Vaccine Global Market Report 2024

Description

An edible vaccine is a type of vaccine developed in genetically modified plants or animals, designed to be delivered through consumption rather than injection. These vaccines stimulate an immune response when an edible plant or food, such as fruits or vegetables, is consumed. This concept aims to provide a cost-effective and easily accessible alternative to traditional vaccines, particularly in developing countries.

The primary types of edible vaccines include inactivated vaccines, subunit vaccines, deoxyribonucleic acid (DNA) vaccines, live attenuated vaccines, and others. Inactivated vaccines are made from viruses or bacteria that have been killed or inactivated so they cannot cause disease, yet still elicit an immune response, such as the polio and hepatitis A vaccines. Distribution channels for these vaccines encompass hospitals, veterinary clinics, retail pharmacies, and online pharmacies. Their applications span medical care, livestock, aquaculture, agriculture, and more. Edible vaccines are utilized by a diverse range of end users, including adults, pediatric populations, and animals.

The edible vaccine market research report is one of a series of new reports from The Business Research Company that provides edible vaccine market statistics, including edible vaccine industry global market size, regional shares, competitors with a edible vaccine market share, detailed edible vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the edible vaccine industry. This edible vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The edible vaccine market size has grown strongly in recent years. It will grow from $8.04 billion in 2023 to $8.77 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period can be attributed to advancements in genetic engineering, challenges associated with traditional vaccines, progress in biopharming, a growing focus on global immunization efforts, and increased funding and support from governments.

The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $12.50 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The projected growth during the forecast period can be attributed to the increasing demand for pandemic preparedness, advancements in plant biotechnology, heightened public awareness and acceptance of genetically modified foods, efforts to address cold chain challenges, and integration with food security initiatives. Key trends anticipated during this period include expansion into animal health, greater utilization of biopharming, personalized nutrition and vaccination approaches, a focus on sustainability and green vaccines, and the development of multi-antigen edible vaccines.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the edible vaccine market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, that invade the body and multiply. The rise in infectious diseases is largely attributed to factors such as globalization, climate change, urbanization, and antibiotic resistance, which facilitate the spread and emergence of new pathogens. Edible vaccines offer a solution for combating infectious diseases by stimulating immune responses through the consumption of genetically modified foods that produce antigens, providing a cost-effective and needle-free immunization method. For instance, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, reported that the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Additionally, the incidence rate per 100,000 people rose from 2.5 in 2022 to 2.9 in 2023. Therefore, the escalating prevalence of infectious diseases is a significant driver of the edible vaccine market.

Key companies in the edible vaccine market are concentrating on developing innovative solutions, such as oral cholera vaccines (OCVs), to address the global cholera crisis. OCVs are vaccines administered orally to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For example, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, launched Hillchol, an oral cholera vaccine with several advantageous features. This live-attenuated vaccine induces both systemic and mucosal immune responses, offering protection against cholera. Hillchol is notable for its ease of administration and the fact that it does not require cold storage, making it suitable for use in resource-limited settings. Additionally, it provides long-lasting immunity with just a single dose.

In May 2022, Ceva Sante Animale, a France-based pharmaceutical company, acquired Artemis Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Ceva Sante Animale's oral rabies vaccine portfolio and expand its presence in wildlife disease management. Artemis Technologies Inc. is a Canada-based company specializing in the provision of oral rabies vaccines.

Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Sante Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation

North America was the largest region in the edible vaccine market in 2023. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the edible vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The edible vaccine market consists of sales of plant-based edible vaccines, animal-based edible vaccines, algae-based edible vaccines, and yeast-based edible vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Edible Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on edible vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for edible vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The edible vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Inactivated Vaccines; Subunit Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Live Attenuated Vaccines; Other Types
2) By Distribution Channel: Hospitals; Veterinary Clinics; Retail Pharmacies; Online Pharmacies
3) By Application: Medical Care; Livestock; Aquaculture; Agriculture; Other Applications
4) By End User: Adults; Pediatrics; Animals
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; GSK plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20214

1. Executive Summary

2. Edible Vaccine Market Characteristics

3. Edible Vaccine Market Trends And Strategies

4. Edible Vaccine Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Edible Vaccine Market Size and Growth

5.1. Global Edible Vaccine Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Edible Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Edible Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Edible Vaccine Market Segmentation

6.1. Global Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Inactivated Vaccines
Subunit Vaccines
Deoxyribonucleic Acid (DNA) Vaccines
Live Attenuated Vaccines
Other Types
6.2. Global Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Veterinary Clinics
Retail Pharmacies
Online Pharmacies
6.3. Global Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medical Care
Livestock
Aquaculture
Agriculture
Other Applications
6.4. Global Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adults
Pediatrics
Animals

7. Edible Vaccine Market Regional And Country Analysis

7.1. Global Edible Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Edible Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Edible Vaccine Market

8.1. Asia-Pacific Edible Vaccine Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Edible Vaccine Market

9.1. China Edible Vaccine Market Overview
9.2. China Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Edible Vaccine Market

10.1. India Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Edible Vaccine Market

11.1. Japan Edible Vaccine Market Overview
11.2. Japan Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Edible Vaccine Market

12.1. Australia Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Edible Vaccine Market

13.1. Indonesia Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Edible Vaccine Market

14.1. South Korea Edible Vaccine Market Overview
14.2. South Korea Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Edible Vaccine Market

15.1. Western Europe Edible Vaccine Market Overview
15.2. Western Europe Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Edible Vaccine Market

16.1. UK Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Edible Vaccine Market

17.1. Germany Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Edible Vaccine Market

18.1. France Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Edible Vaccine Market

19.1. Italy Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Edible Vaccine Market

20.1. Spain Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Edible Vaccine Market

21.1. Eastern Europe Edible Vaccine Market Overview
21.2. Eastern Europe Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Edible Vaccine Market

22.1. Russia Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Edible Vaccine Market

23.1. North America Edible Vaccine Market Overview
23.2. North America Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Edible Vaccine Market

24.1. USA Edible Vaccine Market Overview
24.2. USA Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Edible Vaccine Market

25.1. Canada Edible Vaccine Market Overview
25.2. Canada Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Edible Vaccine Market

26.1. South America Edible Vaccine Market Overview
26.2. South America Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Edible Vaccine Market

27.1. Brazil Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Edible Vaccine Market

28.1. Middle East Edible Vaccine Market Overview
28.2. Middle East Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Edible Vaccine Market

29.1. Africa Edible Vaccine Market Overview
29.2. Africa Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Edible Vaccine Market Competitive Landscape And Company Profiles

30.1. Edible Vaccine Market Competitive Landscape
30.2. Edible Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi S.A.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. GSK plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Edible Vaccine Market Other Major And Innovative Companies

31.1. C.H. Boehringer Sohn AG & Co. KG
31.2. Novavax Inc.
31.3. Ceva Sante Animale
31.4. Sinovac Biotech Ltd.
31.5. Hualan Biological Engineering Inc.
31.6. Zydus Lifesciences Limited
31.7. Bharat Biotech International Limited
31.8. Medicago Inc.
31.9. CureVac N.V.
31.10. Profectus BioSciences Inc.
31.11. Vaxart Inc.
31.12. China National Biotec Group Company Limited
31.13. Vaxine Pty Ltd.
31.14. Vaxiion Therapeutics Inc.
31.15. Therapix Biosciences Ltd.

32. Global Edible Vaccine Market Competitive Benchmarking

33. Global Edible Vaccine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Edible Vaccine Market

35. Edible Vaccine Market Future Outlook and Potential Analysis

35.1 Edible Vaccine Market In 2028 - Countries Offering Most New Opportunities
35.2 Edible Vaccine Market In 2028 - Segments Offering Most New Opportunities
35.3 Edible Vaccine Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer